AstraZeneca: Global Pharmaceutical Cold Chain Cases

Challenge

AstraZeneca is a global biopharmaceutical leader with $50B+ revenue and 100+ countries. They need cases for COVID-19 vaccine samples, oncology drug materials, and clinical trial kits transported to hospitals and labs globally. Cases must: (1) meet IATA + GDP + WHO PQS cold chain standards, (2) maintain 2-8C for 72+ hours, (3) protect $150,000+ pharma cargo, (4) integrate with AstraZeneca supply chain, (5) be reusable 200+ cycles.

Solution

KeXinMaterials provided pharma-grade cold chain cases with: (1) IATA + GDP + WHO PQS + IP65 compliance, (2) PP copolymer with insulated walls and phase-change material chambers, (3) custom foam + PCM for vaccine vials, oncology samples, clinical trial kits, (4) serialized QR + AstraZeneca cold chain logistics, (5) 200+ cycle rating. Custom foam for AZ COVID-19 vaccine, Tagrisso, Imfinzi, Farxiga, Calquence oncology products.

Result

1,400 cases deployed across 100+ countries. 18 months zero temperature excursion. 100% WHO PQS compliance. AstraZeneca standardized KeXinMaterials as a qualified pharma cold chain case vendor.

"AstraZeneca operates in 100+ countries with strict IATA, GDP, and WHO PQS pharmaceutical cold chain standards. KeXinMaterials cases have proven 2-8C maintenance for 72+ hours across our global pharmaceutical distribution including COVID-19 vaccine. The 200+ cycle reusability supports our ESG goals. They're our standard pharma case. — AstraZeneca Global Pharma Logistics Director"

— AstraZeneca PLC

Related Resources

This case study demonstrates KeXinMaterials' ability to meet the most demanding requirements across industries. The same engineering rigor applies across all our 185+ case studies. For similar projects, contact us at kexin@beeaa.com for a 12h custom quote.